Bristol Myers Squibb news from FierceHealthIT
NewsCA bill proposes prescription drug tracking requirement
A bill that would require cradle-to-grave drug tracking in California has sparked extensive debate in the state, with critics contending that the new requirements could impose tens of millions in new Read more...
| Press ReleasesBristol-Myers Squibb to Present at Goldman Sachs Healthcare CEOs Unscripted ConferenceNEW YORK--(BUSINESS WIRE)-- Bristol-Myers Squibb Company (NYSE: BMY) will present at the Goldman Sachs Healthcare CEOs Unscripted conference Thursday, January 6, 2011, in New York. Lamberto Read more >> Newly Published Investigational Apixaban ADVANCE-3 Study Results Demonstrate Statistical Superiority to Enoxaparin with CoPhase 3 Data Published Today in The New England Journal of Medicine PRINCETON, N.J. & NEW YORK--(BUSINESS WIRE)-- Bristol-Myers Squibb Company (NYSE: BMY) and Pfizer Inc. (NYSE: PFE) today Read more >> Maven Semantic: Toxicity Research DatabaseSearch Over 307,000 People and Over 22,000 Toxicity Research Organisations DUBLIN--(BUSINESS WIRE)-- Maven Semantic (http://www.mavensemantic.com) announces updates to their Toxicity research Read more >> Maven Semantic: Antibodies Research DatabaseSearch Over 472,000 People and Over 35,000 Antibodies Research Organisations DUBLIN--(BUSINESS WIRE)-- Maven Semantic (http://www.mavensemantic.com) announces updates to their Antibodies research Read more >> N. Anthony Coles, M.D. Named to LabCorp® Board of DirectorsBURLINGTON, N.C.--(BUSINESS WIRE)-- Laboratory Corporation of America® Holdings (LabCorp®) (NYSE:LH) today announced that N. Anthony Coles, M.D., has been elected to its Board of Directors, effective Read more >> |
